ON CANCER CHEMOPREVENTION - COMPLICATIONS AND LIMITATIONS OF SOME PROPOSED STRATEGIES

被引：9

作者：

PAOLINI, M

MESIRCA, R

GIALLUCA, N

BAUER, C

BIAGI, GL

CANTELLIFORTI, G

机构：

[1] UNIV BARI,DEPT PHARMACOL BIOL,PHARMACOL UNIT,I-40125 BARI,ITALY

[2] DEPT BIOCHEM & PHYSIOL,BIOCHEM LABS,I-56100 PISA,ITALY

[3] UNIV TEXAS,MED BRANCH,DEPT PREVENT MED & COMMUNITY HLTH,DIV ENVIRONM TOXICOL,GALVESTON,TX 77550

来源：

CARCINOGENESIS | 1995年 / 16卷 / 04期

关键词：

D O I：

10.1093/carcin/16.4.971

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：971 / 972

页数：2

共 24 条

[1]

BAST A, 1986, TIPS JUL, P266

[2] METABOLIC POLYMORPHISMS [J].

DALY, AK ;

CHOLERTON, S ;

GREGORY, W ;

IDLE, JR .

PHARMACOLOGY & THERAPEUTICS, 1993, 57 (2-3) :129-160

[3] OXIDATIVE DAMAGE TO DNA DURING AGING - 8-HYDROXY-2'-DEOXYGUANOSINE IN RAT ORGAN DNA AND URINE [J].

FRAGA, CG ;

SHIGENAGA, MK ;

PARK, JW ;

DEGAN, P ;

AMES, BN .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4533-4537

[4] GENETIC-DIFFERENCES IN OXYGEN-TOXICITY ARE CORRELATED WITH CYTOCHROME-P-450 INDUCIBILITY [J].

GONDER, JC ;

PROCTOR, RA ;

WILL, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (18) :6315-6319

[5] CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].

GONZALEZ, FJ ;

SKODA, RC ;

KIMURA, S ;

UMENO, M ;

ZANGER, UM ;

NEBERT, DW ;

GELBOIN, HV ;

HARDWICK, JP ;

MEYER, UA .

NATURE, 1988, 331 (6155) :442-446

[6] EVOLUTION OF THE P450-GENE SUPERFAMILY - ANIMAL PLANT WARFARE, MOLECULAR DRIVE AND HUMAN GENETIC-DIFFERENCES IN DRUG OXIDATION [J].

GONZALEZ, FJ ;

NEBERT, DW .

TRENDS IN GENETICS, 1990, 6 (06) :182-186

[7] ENZYMATIC ACTIVATION OF CHEMICALS TO TOXIC METABOLITES [J].

GUENGERICH, FP ;

LIEBLER, DC .

CRC CRITICAL REVIEWS IN TOXICOLOGY, 1985, 14 (03) :259-307

[8]

HANNA PE, 1992, MOL PHARMACOL, V21, P159

[9] PHARMACOGENETICS - ITS BIOLOGIC ROOTS AND THE MEDICAL CHALLENGE [J].

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (03) :235-241

[10]

KASPER CB, 1980, ENZYMATIC BASIS DETO, P3

← 1 2 3 →